α-Synuclein pathology in LRRK2 Parkinson disease
Nature Reviews Neurology – Absence of Lewy body pathology in the form of Parkinson disease caused by mutations in the LRRK2 gene does not equate to a lack of α-synuclein pathology, two new…
Nature Reviews Neurology – Absence of Lewy body pathology in the form of Parkinson disease caused by mutations in the LRRK2 gene does not equate to a lack of α-synuclein pathology, two new…
Background and objectiveIschemic stroke remains a leading cause of morbidity worldwide, demanding reliable biomarkers and mechanistic insights to inform pers…
Nature Communications – The immune response to tumour development is frequently targeted with therapeutics but remains largely unexplored in diagnostics. Here this groups designs an…
Background and ObjectivesThe quality of evidence for improving physical fitness in people with neuromuscular diseases (NMDs) through aerobic exercise is low. The aim of this…
Dr. Justin Abbatemarco talks with Dr. Eric L. Voorn about the efficacy of combined personalized home-based aerobic exercise and coaching on physical fitness in people…
Background and ObjectivesThe literature on severe West Nile virus (WNV) neuroinvasive disease (WNND) in patients treated with anti-CD20 therapies is limited. We systematically characterize cases…
treatments. The significant findings from the studies on GW veterans are summarized in the following section.A study involving 703 Gulf War (GW) veterans ass…
Quest Diagnostics (Secaucus, NJ) announced plans to begin offering the Lumipulse G pTau 217/β-Amyloid 1-42 diagnostic test (Fujirebio Diagnostics, Malvern…
In part one of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the new global cryptococcal meningitis guidelines. Show reference:
This episode provides a thorough examination of the risk factors associated with the loss of cervical lordosis following laminoplasty in three distinct groups: continuous OPLL,…
Nature Biotechnology – As governments around the world begin to embrace artificial intelligence in healthcare, clinical trials are entering a new phase — faster, smarter…